Results of treatment with doxorubicin, bleomycin, vinblastine and dacarbazine and highly active antiretroviral therapy in advanced stage, human immunodeficiency virus-related Hodgkin's lymphomaBlanca Xicoy, Josep‐María Ribera, Pilar Miralles et al.|Haematologica|2007Cited by 123
Human Immunodeficiency Virus/Hepatits C Virus Coinfection in Spain: Elimination Is Feasible, but the Burden of Residual Cirrhosis Will Be SignificantJuan Berenguer, Inmaculada Jarrín, Leire Pérez‐Latorre et al.|Open Forum Infectious Diseases|2018Cited by 28
Maintenance therapy with dolutegravir and lamivudine versus bictegravir, emtricitabine, and tenofovir alafenamide in people with HIV (PASO-DOBLE): 48-week results from a randomised, multicentre, open-label, non-inferiority trialPablo Ryan, Estebán Martínez, José L Blanco et al.|The Lancet HIV|2025Cited by 22
Changes in Quality of Sleep, Mood, and Other Neuropsychiatric Symptoms After Switching Dolutegravir/Lamivudine/Abacavir to Darunavir/Cobicistat/Emtricitabine/Tenofovir Alafenamide in a Randomized Study of People With Human Immunodeficiency Virus With Poor Sleep Quality: GESIDA 10418Alfonso Cabello, Ignacio Valero, Guillermo Cuevas et al.|Open Forum Infectious Diseases|2022Cited by 12
Limited prognostic value of the International Prognostic Score in advanced stage human immunodeficiency virus infection-related Hodgkin lymphoma treated with the doxorubicin, bleomycin, vinblastine, and dacarbazine regimenBlanca Xicoy, Josep‐María Ribera, Pilar Miralles et al.|Leukemia & lymphoma/Leukemia and lymphoma|2009Cited by 10